Cite
Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.
MLA
Ju, Mengyang, et al. “Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.” Frontiers in Oncology, vol. 11, Jan. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.3389/fonc.2021.789312.
APA
Ju, M., Ge, X., Di, X., Zhang, Y., Liang, L., & Shi, Y. (2022). Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma. Frontiers in Oncology, 11, 1–13. https://doi.org/10.3389/fonc.2021.789312
Chicago
Ju, Mengyang, Xiaolin Ge, Xiaoke Di, Yumeng Zhang, Liang Liang, and Yujing Shi. 2022. “Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma.” Frontiers in Oncology 11 (January): 1–13. doi:10.3389/fonc.2021.789312.